Lin Z, Wu Z, He Y, Li X, Luo W
Mol Med. 2025; 31(1):74.
PMID: 39984834
PMC: 11846196.
DOI: 10.1186/s10020-025-01127-3.
Lukaszewicz M
Pharmaceuticals (Basel). 2024; 17(9).
PMID: 39338357
PMC: 11434898.
DOI: 10.3390/ph17091195.
Liu C, Dou X, Zhao Y, Zhang L, Zhang L, Dai Q
Nat Commun. 2024; 15(1):7421.
PMID: 39198433
PMC: 11358264.
DOI: 10.1038/s41467-024-51634-w.
Aranega A, Franco D
Adv Exp Med Biol. 2024; 1441:313-339.
PMID: 38884719
DOI: 10.1007/978-3-031-44087-8_17.
Ziegenhals T, Frieling R, Wolf P, Gobel K, Koch S, Lohmann M
Front Mol Biosci. 2023; 10:1291045.
PMID: 38146535
PMC: 10749352.
DOI: 10.3389/fmolb.2023.1291045.
TMSC-m7G: A transformer architecture based on multi-sense-scaled embedding features and convolutional neural network to identify RNA N7-methylguanosine sites.
Zhang S, Xu Y, Liang Y
Comput Struct Biotechnol J. 2023; 23:129-139.
PMID: 38089465
PMC: 10714341.
DOI: 10.1016/j.csbj.2023.11.052.
N7-methylguanosine-related miRNAs predict hepatocellular carcinoma prognosis and immune therapy.
Ma L, Ma Q, Deng Q, Zhou J, Zhou Y, Wei Q
Aging (Albany NY). 2023; 15(21):12192-12208.
PMID: 37925170
PMC: 10683595.
DOI: 10.18632/aging.205172.
RNA modification in cardiovascular disease: implications for therapeutic interventions.
Wang C, Hou X, Guan Q, Zhou H, Zhou L, Liu L
Signal Transduct Target Ther. 2023; 8(1):412.
PMID: 37884527
PMC: 10603151.
DOI: 10.1038/s41392-023-01638-7.
m7GHub V2.0: an updated database for decoding the N7-methylguanosine (m7G) epitranscriptome.
Wang X, Zhang Y, Chen K, Liang Z, Ma J, Xia R
Nucleic Acids Res. 2023; 52(D1):D203-D212.
PMID: 37811871
PMC: 10767970.
DOI: 10.1093/nar/gkad789.
An intramolecular disulphide bond in human 4E-T affects its binding to eIF4E1a protein.
Zuberek J, Warzecha M, Dobrowolski M, Modrak-Wojcik A
Eur Biophys J. 2023; 52(6-7):497-510.
PMID: 37798395
PMC: 10618305.
DOI: 10.1007/s00249-023-01684-7.
Chemical Modifications of mRNA Ends for Therapeutic Applications.
Warminski M, Mamot A, Depaix A, Kowalska J, Jemielity J
Acc Chem Res. 2023; 56(20):2814-2826.
PMID: 37782471
PMC: 10586375.
DOI: 10.1021/acs.accounts.3c00442.
Mettl1-mediated internal mG methylation of Sptbn2 mRNA elicits neurogenesis and anti-alzheimer's disease.
Li Q, Liu H, Li L, Guo H, Xie Z, Kong X
Cell Biosci. 2023; 13(1):183.
PMID: 37779199
PMC: 10544167.
DOI: 10.1186/s13578-023-01131-2.
A Novel 7-Methylguanosine (m7G)-Related Gene Signature for Overall Survival Prediction in Patient with Clear Cell Renal Cell Carcinoma.
Fu Y, Wang J, Hu Z, Gou Y, Li Y, Jiang Q
J Oncol. 2023; 2023:9645038.
PMID: 37089261
PMC: 10118881.
DOI: 10.1155/2023/9645038.
mRNA-Based Therapeutics in Cancer Treatment.
Sun H, Zhang Y, Wang G, Yang W, Xu Y
Pharmaceutics. 2023; 15(2).
PMID: 36839944
PMC: 9964383.
DOI: 10.3390/pharmaceutics15020622.
Terminal hairpins improve protein expression in IRES-initiated mRNA in the absence of a cap and polyadenylated tail.
Solodushko V, Fouty B
Gene Ther. 2023; 30(7-8):620-627.
PMID: 36828937
PMC: 9951143.
DOI: 10.1038/s41434-023-00391-4.
Internal m7G methylation: A novel epitranscriptomic contributor in brain development and diseases.
Xia X, Wang Y, Zheng J
Mol Ther Nucleic Acids. 2023; 31:295-308.
PMID: 36726408
PMC: 9883147.
DOI: 10.1016/j.omtn.2023.01.003.
Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J, Liang Y, Gu J, Huang Y, Wang B
Front Genet. 2022; 13:991162.
PMID: 36353118
PMC: 9639662.
DOI: 10.3389/fgene.2022.991162.
CAPturAM, a Chemo-Enzymatic Strategy for Selective Enrichment and Detection of Physiological CAPAM-Targets.
Muthmann N, Albers M, Rentmeister A
Angew Chem Int Ed Engl. 2022; 62(4):e202211957.
PMID: 36282111
PMC: 10107118.
DOI: 10.1002/anie.202211957.
Eukaryotic mRNA decapping factors: molecular mechanisms and activity.
He F, Jacobson A
FEBS J. 2022; 290(21):5057-5085.
PMID: 36098474
PMC: 10008757.
DOI: 10.1111/febs.16626.
Recent advances in functional annotation and prediction of the epitranscriptome.
Zhang S, Zhang S, Zhang T, Fan X, Meng J
Comput Struct Biotechnol J. 2021; 19:3015-3026.
PMID: 34136099
PMC: 8175281.
DOI: 10.1016/j.csbj.2021.05.030.